WASHINGTON, D.C. and ATLANTA -- The Centers for Disease Control and Prevention (CDC) has issued interim guidance advising states that persons investigating monkeypox outbreaks and involved in caring for infected individuals or animals should receive a smallpox vaccination to protect against the possibility of contracting monkeypox. CDC is also recommending that persons who have had close or intimate contact with individuals or animals confirmed to have monkeypox should also be vaccinated. They can be vaccinated up to 14 days post-exposure.
CDC is not recommending smallpox vaccination for veterinarians, veterinary staff or animal control officers who have not been exposed. However, the public health agency does encourage such personnel to use standard infection control measures to prevent contact or airborne transmission of the virus if they are involved in investigation or treatment of ill animals.
"This outbreak demonstrates the importance of preparedness for the unexpected," said Tommy G. Thompson, secretary of the Department of Health and Human Services. "State health departments have been actively involved in planning and preparing for the possibility of a bioterrorist event. We are now seeing that this level of preparation can also assist in unexpected, natural outbreaks."
"Monkeypox can be a serious illness, and it has not been previously seen in humans in this hemisphere. CDC and a team of expert advisors carefully weighed the risk of smallpox vaccination against the risks posed by exposure to monkeypox infection in arriving at this important decision," said Dr. Julie Gerberding, CDC director. "We must do everything we can to protect persons who are exposed to monkeypox in the course of investigating or responding to this outbreak."
CDC also issued a case definition for human cases of monkeypox. The agency cautioned that it is important to confirm suspected cases of monkeypox before recommending vaccination in instances where there is close or intimate contact between persons with rash illness and persons who have contraindications for smallpox vaccination, such as pregnancy or eczema.
CDC has also issued interim guidance for veterinarians and pet owners who may be in contact with ill prairie dogs or exotic rodents from Africa. CDC strongly cautions pet owners not to release these animals to the wild but to contact their state health departments for guidance if there is any concern about the health of an exotic rodent or prairie dog acquired as a pet after April 15, 2003.
Persons who should be alert to their health status are those who have been exposed to an exotic rodent or a prairie dog that is exhibiting signs of illness, such as conjunctivitis, respiratory symptoms and/or rash, or an animal that itself has been in contact with a case of monkeypox in either a pet or a human. Exposure includes living in a household, petting, handling or visiting a pet holding facility -- such as a pet store, veterinary clinic or pet distributor -- where ill animals have been identified.
Source: CDC
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.